Serious Illness Communication Training Available

The Center for Advancing Serious Illness Communication (CASIC), a joint initiative of the Minnesota Medical Association (MMA) and Minnesota Hospital Association (MHA), has launched its first series of on-demand training to introduce healthcare providers and other members of care teams to serious illness conversations (SIC).

This three-module introductory training series begins the process of preparing clinicians and healthcare organizations to engage every patient experiencing a serious illness in meaningful discussions about their diagnosis, prognosis and care choices. It focuses on the Serious Illness Communication Guide, an evidence-based tool developed by Ariadne Labs, which is a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health.

The free training is available to all members of care teams who work with patients with serious illnesses. These modules are CME-eligible for physicians.

Live Interactive CME Webcast: Homozygous Hypercholesterolemia

Closeup photograph of doctor writing on a clipboard

Join Us for a Live Interactive CME Webcast!

“Cross-Setting Strategies for Improved Identification, Diagnosis, and Management of Homozygous Hypercholesterolemia” will take place virtually on Wednesday, October 25, 2023 at 6:00 PM CT.

This webcast was organized for the ACC Great Plains, Iowa and Minnesota Chapters.

Program Overview

Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular disease. Affected individuals are typically less responsive or unresponsive to standard lipid-lowering therapies (ie, statins and PCSK9 inhibitors) and may benefit from treatments with alternative mechanisms of action, such as the recently FDA-approved ANGPTL3 inhibitor evinacumab. With this in mind, this program has been designed to educate clinicians about the prevalence of HoFH, the importance of HoFH screening, and the benefits and limitations of current therapies for lipid management in patients with the disease. The nationally recognized expert faculty will also provide practical advice to attendees, based on their personal success, regarding strategies that improve patient access to newer lipid-lowering therapies.

Target Audience

This educational activity has been designed for US cardiologists and internal medicine physicians, nurse practitioners, and physician assistants involved in the identification, diagnosis, and management of patients with HoFH.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.

Faculty Presenter

Mary McGowan, MD
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Lipid Clinic & Lipid Research
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Live Interactive CME Webcast: Homozygous Hypercholesterolemia

Closeup photograph of doctor writing on a clipboard

Join Us for a Live Interactive CME Webcast!

Cross-Setting Strategies for Improved Identification, Diagnosis, and Management of Homozygous Hypercholesterolemia

Wednesday, October 25, 2023 | 6:00 PM CT

Program Overview

Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular disease. Affected individuals are typically less responsive or unresponsive to standard lipid-lowering therapies (ie, statins and PCSK9 inhibitors) and may benefit from treatments with alternative mechanisms of action, such as the recently FDA-approved ANGPTL3 inhibitor evinacumab. With this in mind, this program has been designed to educate clinicians about the prevalence of HoFH, the importance of HoFH screening, and the benefits and limitations of current therapies for lipid management in patients with the disease. The nationally recognized expert faculty will also provide practical advice to attendees, based on their personal success, regarding strategies that improve patient access to newer lipid-lowering therapies.

Target Audience

This educational activity has been designed for US cardiologists and internal medicine physicians, nurse practitioners, and physician assistants involved in the identification, diagnosis, and management of patients with HoFH.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.

Faculty Presenter

Mary McGowan, MD
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Lipid Clinic & Lipid Research
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Register Now: Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Disease Overview, Image Findings, and Case Study

Photograph of black stethoscope and red heart toy against an orange background

Register now for this upcoming two-part webinar series.

Learning Objectives:

  1. Review cardiac amyloidosis and its pathogenesis, subtypes, prevalence and the importance of identification of ATTR-CM.
  2. Identify signs, symptoms and modalities used for screening for ATTR-CM in everyday practice.
  3. Discuss the Multi-Societal Expert Consensus Recommendations (MECR) on imaging cardiac amyloidosis and describe the role of echocardiography, cardiovascular magnetic resonance (CMR) and nuclear scintigraphy in diagnosing and typing of patients with suspected or known cardiac amyloidosis.
  4. Review and discuss a patient case study.

Speaker:

Tamara S. Evans, BS, Pharm.D., MPH, PAHM
Senior Medical Director, Pfizer Inc
US Medical Affairs, Rare Cardiology

Register Now: 2023 FIT Echo Bootcamp

Registration is now open for our fourth annual FIT Echo Bootcamp! Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies. This four-part virtual series is led by Dr. Richard H. Marcus of the Iowa Heart Center.

Dr. Rick Marcus is one of the nation’s leading experts in the use of echocardiography to diagnose heart disease. Read more.

Bootcamp Dates:

  • July 10
  • July 12
  • July 17
  • July 19

Save the Date: 2023 FIT Echo Bootcamp

Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies. This four-part virtual series is led by Dr. Rick Marcus of the Iowa Heart Center.

Dr. Richard Marcus is one of the nation’s leading experts in the use of echocardiography to diagnose heart disease. Read more.

Bootcamp Dates:

  • July 10
  • July 12
  • July 17
  • July 19

More information coming soon.

1 2 3 4